Literature DB >> 27149640

Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.

Ahmed I Salem1, Matthew R Thau2, Tobin J Strom3, Andrea M Abbott4, Nadia Saeed5, Khaldoun Almhanna5, Sarah E Hoffe3, Ravi Shridhar3, Richard C Karl4, Kenneth L Meredith1.   

Abstract

The impact of body weight on outcomes after robotic-assisted esophageal surgery for cancer has not been studied. We examined the short-term operative outcomes in patients according to their body mass index following robotic-assisted Ivor-Lewis esophagectomy at a high-volume tertiary-care referral cancer center and evaluated the safety of robotic surgery in patients with an elevated body mass index. A retrospective review of all patients who underwent robotic-assisted Ivor-Lewis esophagectomy between April 2010 and June 2013 for pathologically confirmed distal esophageal cancer was conducted. Patient demographics, clinicopathologic data, and operative outcomes were collected. We stratified body mass index at admission for surgery according to World Health Organization criteria; normal range is defined as a body mass index range of 18.5-24.9 kg/m2. Overweight is defined as a body mass index range of 25.0-29.9 kg/m2 and obesity is defined as a body mass index of 30 kg/m2 and above. Statistics were calculated using Pearson's Chi-square and Pearson's correlation coefficient tests with a P-value of 0.05 or less for significance. One hundred and twenty-nine patients (103 men, 26 women) with median age of 67 (30-84) years were included. The majority of patients, 76% (N = 98) received neoadjuvant therapy. When stratified by body mass index, 28 (22%) were normal weight, 56 (43%) were overweight, and 45 (35%) were obese. All patients had R0 resection. Median operating room time was 407 (239-694) minutes. When stratified by body mass index, medians of operating room time across the normal weight, overweight and obese groups were 387 (254-660) minutes, 395 (310-645) minutes and 445 (239-694), respectively. Median estimated blood loss (EBL) was 150 (25-600) cc. When stratified by body mass index, medians of EBL across the normal weight, overweight and obese groups were 100 (50-500) cc, 150 (25-600) cc and 150 (25-600), respectively. Obesity significantly correlated with longer operating room time (P = 0.05) but without significant increased EBL (P = 0.348). Among the three body mass index groups there was no difference in postoperative complications including thrombotic events (pulmonary embolism and deep venous thrombosis) (P = 0.266), pneumonia (P = 0.189), anastomotic leak (P = 0.090), wound infection (P = 0.390), any cardiac events (P = 0.793) or 30 days mortality (P = 0.414). Our data study demonstrates that patients with esophageal cancer and an elevated body mass index undergoing robotic-assisted Ivor-Lewis esophagectomy have increased operative times but no significantly increased EBL during the procedure. Other potential morbidities did not differ with the robotic approach.
© 2016 International Society for Diseases of the Esophagus.

Entities:  

Keywords:  Ivor Lewis; body mass index; da Vinci; esophageal cancer surgery; esophagectomy; robotic surgery

Mesh:

Year:  2017        PMID: 27149640     DOI: 10.1111/dote.12484

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  7 in total

1.  Impact of Excess Body Weight on Postsurgical Complications.

Authors:  Lars Plassmeier; Mohammed K Hankir; Florian Seyfried
Journal:  Visc Med       Date:  2021-08-02

Review 2.  Upper Gastrointestinal Surgery: Robotic Surgery versus Laparoscopic Procedures for Esophageal Malignancy.

Authors:  Matthias Biebl; Andreas Andreou; Sascha Chopra; Christian Denecke; Johann Pratschke
Journal:  Visc Med       Date:  2018-02-16

Review 3.  Robotic-assisted Ivor Lewis esophagectomy: technique and early outcomes.

Authors:  Ian Nora; Ravi Shridhar; Kenneth Meredith
Journal:  Robot Surg       Date:  2017-09-27

4.  Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer.

Authors:  Rong Yang; Yihe Wu; Linpeng Yao; Jinming Xu; Siying Zhang; Chengli Du; Feng Chen
Journal:  Ther Clin Risk Manag       Date:  2019-02-04       Impact factor: 2.423

5.  Impact of body mass index on perioperative and oncological outcomes in elderly patients undergoing minimally invasive McKeown esophagectomy for esophageal squamous cell carcinoma.

Authors:  Chaoyang Tong; Huijie Lu; Hongwei Zhu; Jingxiang Wu
Journal:  Cancer Med       Date:  2022-03-21       Impact factor: 4.711

6.  Anastomotic leak and neoadjuvant chemoradiotherapy in esophageal cancer.

Authors:  Ravi Shridhar; Caitlin Takahashi; Jamie Huston; Matthew P Doepker; Kenneth L Meredith
Journal:  J Gastrointest Oncol       Date:  2018-10

Review 7.  Robotic surgery for esophageal cancer: Merits and demerits.

Authors:  Yasuyuki Seto; Kazuhiko Mori; Susumu Aikou
Journal:  Ann Gastroenterol Surg       Date:  2017-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.